Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Hisanori, Kobayashi"'
Autor:
Masakazu Umezawa, Hisanori Kobayashi, Kotoe Ichihashi, Shota Sekiyama, Kyohei Okubo, Masao Kamimura, Kohei Soga
Publikováno v:
ACS Omega, Vol 7, Iss 7, Pp 5817-5824 (2022)
Externí odkaz:
https://doaj.org/article/81df6becd3984ff583361cd7c581ace9
Autor:
Yuichi Ueya, Masakazu Umezawa, Yuka Kobayashi, Hisanori Kobayashi, Kotoe Ichihashi, Takashi Matsuda, Eiji Takamoto, Masao Kamimura, Kohei Soga
Publikováno v:
ACS Nanoscience Au, Vol 1, Iss 1, Pp 61-68 (2021)
Externí odkaz:
https://doaj.org/article/40dc70a82f234b47bd8cc6bd3d68886d
Publikováno v:
Rheumatology and Therapy, Vol 7, Iss 2, Pp 311-325 (2020)
Abstract Introduction While dose escalation of golimumab has been used for patients with rheumatoid arthritis who demonstrate an inadequate response to the standard dose, its effectiveness has not been fully evaluated. The aim of this study was to as
Externí odkaz:
https://doaj.org/article/78796c43fe4c4d0f906750a03504d197
Autor:
Ulrike Schaede, Jörg Mahlich, Masahiko Nakayama, Hisanori Kobayashi, Yuriko Takahashi, Katsuhiko Saito, Hiroji Uemura, Masayuki Tokumitsu, Kazutake Yoshizawa
Publikováno v:
Journal of Global Oncology, Vol 4, Pp 1-9 (2017)
This article adds the Japanese perspective to our knowledge of shared decision-making (SDM) preferences by surveying patients with prostate cancer (PCA) and physicians in Japan. In 2015, 103 Japanese patients with PCA were asked about their SDM prefe
Externí odkaz:
https://doaj.org/article/dba53e73c71a471ab774eb2ad92c4657
Publikováno v:
Psychiatry and Clinical Neurosciences. 76:377-383
The aim of this study is to determine whether there is difference in the change in each symptom of depression and in symptomatic improvement pattern between placebo and antidepressant responses.Using data from a randomized, double-blind (DB), placebo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40c2b7437948f9992cd7c89946538d37
https://doi.org/10.1111/pcn.13379
https://doi.org/10.1111/pcn.13379
Autor:
Yuka Kobayashi, Kohei Soga, Kotoe Ichihashi, Eiji Takamoto, Hisanori Kobayashi, Yuichi Ueya, Takashi Matsuda, Masakazu Umezawa, Masao Kamimura
Publikováno v:
Analytical Sciences. 38:199-205
Polymeric micellar nanoparticles (PNPs) composed of an amphiphilic block copolymer formed from hydrophilic and hydrophobic blocks and over-thousand-nanometer (OTN) near-infrared (NIR) fluorescent dye are promising fluorophores for the dynamic imaging
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f89bad1ecb2e3b3b471c1f56d7a58f50
https://doi.org/10.2116/analsci.21p283
https://doi.org/10.2116/analsci.21p283
Publikováno v:
Rheumatology and Therapy, Vol 7, Iss 4, Pp 1053-1053 (2020)
Under Results section, heading: Effectiveness of GLM Stratified by the Time to Dose Escalation, the remission based on values of DAS28, SDAI, and CDAI was published incorrectly. The correct values are: 16.1%, 5.0% and 4.3%
Externí odkaz:
https://doaj.org/article/bbb9e2d98e2f4d5389f5188100a123d2
Autor:
Masahiko Nakayama, Hisanori Kobayashi, Masateru Okazaki, Keiichiro Imanaka, Kazutake Yoshizawa, Jörg Mahlich
Publikováno v:
American Journal of Men's Health, Vol 12 (2018)
The purpose of the present study is to investigate the concordance of treatment preferences between patients and physicians in prostate cancer (PCa) in Japan. An internet-based discrete choice experiment was conducted. Patients and physicians were as
Externí odkaz:
https://doaj.org/article/75114d80dd4c4c9d97be5d642a44b1bc
Autor:
Kohei Soga, Masakazu Umezawa, Yuka Kobayashi, Eiji Takamoto, Kotoe Ichihashi, Masao Kamimura, Hisanori Kobayashi, Yuichi Ueya, Takashi Matsuda
Publikováno v:
ACS Nanoscience Au. 1:61-68
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2935fee918228dc9ad4d30d917df9da
https://doi.org/10.1021/acsnanoscienceau.1c00010
https://doi.org/10.1021/acsnanoscienceau.1c00010
Publikováno v:
Neuropsychiatric Disease and Treatment
Takashi Ohnishi,1 Akihide Wakamatsu,1 Hisanori Kobayashi2 1Medical Affairs Division, Janssen Pharmaceutical K.K., Tokyo, Japan; 2Research and Development Clinical Science Division, Janssen Pharmaceutical K.K., Tokyo, JapanCorrespondence: Takashi Ohni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d08d53b5fc79478db55785bd9a6a0964
http://europepmc.org/articles/PMC8057833
http://europepmc.org/articles/PMC8057833